Comparison of the Uptake of Hepatocellular Carcinoma on Pre-Therapeutic MDCT, CACT, and SPECT/CT, and the Correlation with Post-Therapeutic PET/CT in Patients Undergoing Selective Internal Radiation Therapy

(1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector computed tomography (MDCT), the parenchymal phase C-arm computed tomography (CACT), the Technetium99m-macroaggregates of human serum albumin...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of clinical medicine Ročník 10; číslo 17; s. 3837
Hlavní autori: Meine, Timo C., Brunkhorst, Thomas, Werncke, Thomas, Schütze, Christian, Vogel, Arndt, Kirstein, Martha M., Dewald, Cornelia L. A., Becker, Lena S., Maschke, Sabine K., Kretschmann, Nils, Wacker, Frank K., Hinrichs, Jan B., Meyer, Bernhard C.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Basel MDPI AG 26.08.2021
MDPI
Predmet:
ISSN:2077-0383, 2077-0383
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract (1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector computed tomography (MDCT), the parenchymal phase C-arm computed tomography (CACT), the Technetium99m-macroaggregates of human serum albumin single-photon emission computed tomography/computed tomography (SPECT/CT), and the correlation to the post-therapeutic Yttrium90 positron emission tomography/computed tomography (PET/CT) in patients with selective internal radiation therapy (SIRT). (2) Methods: Between September 2013 and December 2016, 104 SIRT procedures were performed at our institution in 74 patients with HCC not suitable for curative surgery or ablation. Twenty-two patients underwent an identical sequence of pre-therapeutic MDCT, CACT, SPECT/CT, and post-therapeutic PET/CT with a standardized diagnostic and therapeutic protocol. In these 22 patients, 25 SIRT procedures were evaluated. The uptake of the HCC was assessed using tumor-background ratio (TBR). Therefore, regions of interest were placed on the tumor and the adjacent liver tissue on MDCT (TBRMDCT), CACT (TBRCACT), SPECT/CT (TBRSPECT/CT), and PET/CT (TBRPET/CT). Comparisons were made with the Friedman test and the Nemenyi post-hoc test. Correlations were analyzed using Spearman’s Rho and the Benjamini–Hochberg method. The level of significance was p < 0.05. (3) Results: TBR on MDCT (1.4 ± 0.3) was significantly smaller than on CACT (1.9 ± 0.6) and both were significantly smaller compared to SPECT/CT (4.6 ± 2.0) (pFriedman-Test < 0.001; pTBRMDCT/TBRCACT = 0.012, pTBRMDCT/TBRSPECT/CT < 0.001, pTBRCACT/TBRSPECT/CT < 0.001). There was no significant correlation of TBR on MDCT with PET/CT (rTBRMDCT/TBRPET/CT = 0.116; p = 0.534). In contrast, TBR on CACT correlated to TBR on SPECT/CT (rTBRCACT/TBRSPECT/CT = 0.489; p = 0.004) and tended to correlate to TBR on PET/CT (rTBRCACT/TBRPET/CT =0.365; p = 0.043). TBR on SPECT/CT correlated to TBR on PET/CT (rTBRSPECT/CT/TBRPET/CT = 0.706; p < 0.001) (4) Conclusion: The uptake assessment on CACT was in agreement with SPECT/CT and might be consistent with PET/CT. In contrast, MDCT was not comparable to CACT and SPECT/CT, and had no correlation with PET/CT due to the different application techniques. This emphasizes the value of the CACT, which has the potential to improve the dosimetric assessment of the tumor and liver uptake for SIRT.
AbstractList (1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector computed tomography (MDCT), the parenchymal phase C-arm computed tomography (CACT), the Technetium99m-macroaggregates of human serum albumin single-photon emission computed tomography/computed tomography (SPECT/CT), and the correlation to the post-therapeutic Yttrium90 positron emission tomography/computed tomography (PET/CT) in patients with selective internal radiation therapy (SIRT). (2) Methods: Between September 2013 and December 2016, 104 SIRT procedures were performed at our institution in 74 patients with HCC not suitable for curative surgery or ablation. Twenty-two patients underwent an identical sequence of pre-therapeutic MDCT, CACT, SPECT/CT, and post-therapeutic PET/CT with a standardized diagnostic and therapeutic protocol. In these 22 patients, 25 SIRT procedures were evaluated. The uptake of the HCC was assessed using tumor-background ratio (TBR). Therefore, regions of interest were placed on the tumor and the adjacent liver tissue on MDCT (TBRMDCT), CACT (TBRCACT), SPECT/CT (TBRSPECT/CT), and PET/CT (TBRPET/CT). Comparisons were made with the Friedman test and the Nemenyi post-hoc test. Correlations were analyzed using Spearman's Rho and the Benjamini-Hochberg method. The level of significance was p < 0.05. (3) Results: TBR on MDCT (1.4 ± 0.3) was significantly smaller than on CACT (1.9 ± 0.6) and both were significantly smaller compared to SPECT/CT (4.6 ± 2.0) (pFriedman-Test < 0.001; pTBRMDCT/TBRCACT = 0.012, pTBRMDCT/TBRSPECT/CT < 0.001, pTBRCACT/TBRSPECT/CT < 0.001). There was no significant correlation of TBR on MDCT with PET/CT (rTBRMDCT/TBRPET/CT = 0.116; p = 0.534). In contrast, TBR on CACT correlated to TBR on SPECT/CT (rTBRCACT/TBRSPECT/CT = 0.489; p = 0.004) and tended to correlate to TBR on PET/CT (rTBRCACT/TBRPET/CT =0.365; p = 0.043). TBR on SPECT/CT correlated to TBR on PET/CT (rTBRSPECT/CT/TBRPET/CT = 0.706; p < 0.001) (4) Conclusion: The uptake assessment on CACT was in agreement with SPECT/CT and might be consistent with PET/CT. In contrast, MDCT was not comparable to CACT and SPECT/CT, and had no correlation with PET/CT due to the different application techniques. This emphasizes the value of the CACT, which has the potential to improve the dosimetric assessment of the tumor and liver uptake for SIRT.(1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector computed tomography (MDCT), the parenchymal phase C-arm computed tomography (CACT), the Technetium99m-macroaggregates of human serum albumin single-photon emission computed tomography/computed tomography (SPECT/CT), and the correlation to the post-therapeutic Yttrium90 positron emission tomography/computed tomography (PET/CT) in patients with selective internal radiation therapy (SIRT). (2) Methods: Between September 2013 and December 2016, 104 SIRT procedures were performed at our institution in 74 patients with HCC not suitable for curative surgery or ablation. Twenty-two patients underwent an identical sequence of pre-therapeutic MDCT, CACT, SPECT/CT, and post-therapeutic PET/CT with a standardized diagnostic and therapeutic protocol. In these 22 patients, 25 SIRT procedures were evaluated. The uptake of the HCC was assessed using tumor-background ratio (TBR). Therefore, regions of interest were placed on the tumor and the adjacent liver tissue on MDCT (TBRMDCT), CACT (TBRCACT), SPECT/CT (TBRSPECT/CT), and PET/CT (TBRPET/CT). Comparisons were made with the Friedman test and the Nemenyi post-hoc test. Correlations were analyzed using Spearman's Rho and the Benjamini-Hochberg method. The level of significance was p < 0.05. (3) Results: TBR on MDCT (1.4 ± 0.3) was significantly smaller than on CACT (1.9 ± 0.6) and both were significantly smaller compared to SPECT/CT (4.6 ± 2.0) (pFriedman-Test < 0.001; pTBRMDCT/TBRCACT = 0.012, pTBRMDCT/TBRSPECT/CT < 0.001, pTBRCACT/TBRSPECT/CT < 0.001). There was no significant correlation of TBR on MDCT with PET/CT (rTBRMDCT/TBRPET/CT = 0.116; p = 0.534). In contrast, TBR on CACT correlated to TBR on SPECT/CT (rTBRCACT/TBRSPECT/CT = 0.489; p = 0.004) and tended to correlate to TBR on PET/CT (rTBRCACT/TBRPET/CT =0.365; p = 0.043). TBR on SPECT/CT correlated to TBR on PET/CT (rTBRSPECT/CT/TBRPET/CT = 0.706; p < 0.001) (4) Conclusion: The uptake assessment on CACT was in agreement with SPECT/CT and might be consistent with PET/CT. In contrast, MDCT was not comparable to CACT and SPECT/CT, and had no correlation with PET/CT due to the different application techniques. This emphasizes the value of the CACT, which has the potential to improve the dosimetric assessment of the tumor and liver uptake for SIRT.
(1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector computed tomography (MDCT), the parenchymal phase C-arm computed tomography (CACT), the Technetium99m-macroaggregates of human serum albumin single-photon emission computed tomography/computed tomography (SPECT/CT), and the correlation to the post-therapeutic Yttrium90 positron emission tomography/computed tomography (PET/CT) in patients with selective internal radiation therapy (SIRT). (2) Methods: Between September 2013 and December 2016, 104 SIRT procedures were performed at our institution in 74 patients with HCC not suitable for curative surgery or ablation. Twenty-two patients underwent an identical sequence of pre-therapeutic MDCT, CACT, SPECT/CT, and post-therapeutic PET/CT with a standardized diagnostic and therapeutic protocol. In these 22 patients, 25 SIRT procedures were evaluated. The uptake of the HCC was assessed using tumor-background ratio (TBR). Therefore, regions of interest were placed on the tumor and the adjacent liver tissue on MDCT (TBRMDCT), CACT (TBRCACT), SPECT/CT (TBRSPECT/CT), and PET/CT (TBRPET/CT). Comparisons were made with the Friedman test and the Nemenyi post-hoc test. Correlations were analyzed using Spearman’s Rho and the Benjamini–Hochberg method. The level of significance was p < 0.05. (3) Results: TBR on MDCT (1.4 ± 0.3) was significantly smaller than on CACT (1.9 ± 0.6) and both were significantly smaller compared to SPECT/CT (4.6 ± 2.0) (pFriedman-Test < 0.001; pTBRMDCT/TBRCACT = 0.012, pTBRMDCT/TBRSPECT/CT < 0.001, pTBRCACT/TBRSPECT/CT < 0.001). There was no significant correlation of TBR on MDCT with PET/CT (rTBRMDCT/TBRPET/CT = 0.116; p = 0.534). In contrast, TBR on CACT correlated to TBR on SPECT/CT (rTBRCACT/TBRSPECT/CT = 0.489; p = 0.004) and tended to correlate to TBR on PET/CT (rTBRCACT/TBRPET/CT =0.365; p = 0.043). TBR on SPECT/CT correlated to TBR on PET/CT (rTBRSPECT/CT/TBRPET/CT = 0.706; p < 0.001) (4) Conclusion: The uptake assessment on CACT was in agreement with SPECT/CT and might be consistent with PET/CT. In contrast, MDCT was not comparable to CACT and SPECT/CT, and had no correlation with PET/CT due to the different application techniques. This emphasizes the value of the CACT, which has the potential to improve the dosimetric assessment of the tumor and liver uptake for SIRT.
Author Becker, Lena S.
Hinrichs, Jan B.
Kirstein, Martha M.
Werncke, Thomas
Schütze, Christian
Meyer, Bernhard C.
Meine, Timo C.
Dewald, Cornelia L. A.
Kretschmann, Nils
Wacker, Frank K.
Maschke, Sabine K.
Brunkhorst, Thomas
Vogel, Arndt
AuthorAffiliation 4 Department of Radiation Protection and Medical Physics, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
5 Department of Hepatology, Gastroenterology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; vogel.arndt@mh-hannover.de
3 Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Straße 40, 37075 Goettingen, Germany; christian.schütze@med.uni-goettingen.de
6 1st Department of Medicine, University Medical Center Schleswig-Holstein Luebeck Campus, Ratzeburger Allee 160, 23562 Luebeck, Germany; martha.kirstein@uksh.de
1 Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; meine.timo@mh-hannover.de (T.C.M.); werncke.thomas@mh-hannover.de (T.W.); dewald.cornelia@mh-hannover.de (C.L.A.D.); becker.lena@mh-hannover.de (L.S.B.); maschke.sabine@mh-hannover.de (S.K.M.); nils.kretschman@stud.mh-hannover.de (N.K.); wacker.frank@mh-ha
AuthorAffiliation_xml – name: 5 Department of Hepatology, Gastroenterology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; vogel.arndt@mh-hannover.de
– name: 1 Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; meine.timo@mh-hannover.de (T.C.M.); werncke.thomas@mh-hannover.de (T.W.); dewald.cornelia@mh-hannover.de (C.L.A.D.); becker.lena@mh-hannover.de (L.S.B.); maschke.sabine@mh-hannover.de (S.K.M.); nils.kretschman@stud.mh-hannover.de (N.K.); wacker.frank@mh-hannover.de (F.K.W.); meyer.bernhard@mh-hannover.de (B.C.M.)
– name: 3 Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Straße 40, 37075 Goettingen, Germany; christian.schütze@med.uni-goettingen.de
– name: 6 1st Department of Medicine, University Medical Center Schleswig-Holstein Luebeck Campus, Ratzeburger Allee 160, 23562 Luebeck, Germany; martha.kirstein@uksh.de
– name: 4 Department of Radiation Protection and Medical Physics, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
– name: 2 Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; brunkhorst.thomas@mh-hannover.de
Author_xml – sequence: 1
  givenname: Timo C.
  surname: Meine
  fullname: Meine, Timo C.
– sequence: 2
  givenname: Thomas
  surname: Brunkhorst
  fullname: Brunkhorst, Thomas
– sequence: 3
  givenname: Thomas
  surname: Werncke
  fullname: Werncke, Thomas
– sequence: 4
  givenname: Christian
  surname: Schütze
  fullname: Schütze, Christian
– sequence: 5
  givenname: Arndt
  orcidid: 0000-0003-0560-5538
  surname: Vogel
  fullname: Vogel, Arndt
– sequence: 6
  givenname: Martha M.
  surname: Kirstein
  fullname: Kirstein, Martha M.
– sequence: 7
  givenname: Cornelia L. A.
  surname: Dewald
  fullname: Dewald, Cornelia L. A.
– sequence: 8
  givenname: Lena S.
  surname: Becker
  fullname: Becker, Lena S.
– sequence: 9
  givenname: Sabine K.
  surname: Maschke
  fullname: Maschke, Sabine K.
– sequence: 10
  givenname: Nils
  surname: Kretschmann
  fullname: Kretschmann, Nils
– sequence: 11
  givenname: Frank K.
  surname: Wacker
  fullname: Wacker, Frank K.
– sequence: 12
  givenname: Jan B.
  surname: Hinrichs
  fullname: Hinrichs, Jan B.
– sequence: 13
  givenname: Bernhard C.
  orcidid: 0000-0003-0278-5481
  surname: Meyer
  fullname: Meyer, Bernhard C.
BookMark eNptksFu1DAQhi1URMvSEy9giQsShNpxdpNckKqwtJWKWNHdczRxJrteEju1naK-JM-E07RVW-GDx2N_82v822_JgTYaCXnP2Rchcnaylx1nPBWZSF-Ro5ilacRCcvBkfUiOnduzMLIsiXn6hhyKZM54nCVH5G9huh6sckZT01C_Q7rpPfzGMTvHHryR2LZDC5YWYKXSpgMa4JXFaL1DCz0OXkn641ux_kyL03EGXdOr1bJYnzxko25hrMUWvArVf5Tf0ZVx_pnGajlWUBXUA4baO7rRNdqtUXpLr7BF6dUN0gvt0Wpo6S-o1SQ4ydy-I68baB0e38cZ2Xxfrovz6PLn2UVxehlJkS18lMRCBg-gyYJJeYU5m_M8S6qmwqqGBMN-1aSccxAoWVPnuUhYCguQDHjNUMzI10m3H6oOaxl6tdCWvVUd2NvSgCqfn2i1K7fmpswSEY-PMiMf7wWsuR7Q-bJTbnQaNJrBlfE85XnMQwjohxfo3gzj9SdK8JQtRKA-TZS0xjmLzWMznJXjVymffJVA8xe0VP7OydCtav9b8w_EvsQC
CitedBy_id crossref_primary_10_3390_jcm11237245
Cites_doi 10.1088/2057-1976/ab36c2
10.1016/S1470-2045(17)30683-6
10.1007/s00330-015-4203-4
10.1007/s00270-019-02198-6
10.1186/s40658-017-0192-5
10.1055/s-0030-1247133
10.1007/s00330-006-0508-7
10.2214/AJR.07.2695
10.1016/j.acra.2011.12.015
10.1055/s-0030-1247132
10.1053/j.tvir.2019.02.011
10.1118/1.4725711
10.1007/s00270-018-2030-0
10.1186/s13550-019-0533-6
10.1016/j.diii.2020.09.003
10.1016/j.jhep.2019.08.006
10.1186/s13550-019-0485-x
10.1007/s00270-015-1180-6
10.1016/j.jvir.2013.11.005
10.2967/jnumed.115.162685
10.1200/JCO.2017.76.0892
10.2967/jnumed.115.169987
10.1007/s00259-016-3438-x
10.1007/s00259-013-2395-x
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/jcm10173837
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
CrossRef

Database_xml – sequence: 1
  dbid: PIMPY
  name: ProQuest Publicly Available Content
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-0383
ExternalDocumentID PMC8432038
10_3390_jcm10173837
GeographicLocations United States--US
Germany
Chicago Illinois
GeographicLocations_xml – name: United States--US
– name: Germany
– name: Chicago Illinois
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFFHD
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
HMCUK
HYE
IAO
IHR
ITC
KQ8
M48
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c386t-423c345af80779be9051984bfbebda4ef80bf7111a3ec0fd993407a6ac0a1d0e3
IEDL.DBID BENPR
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000694392600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2077-0383
IngestDate Tue Nov 04 02:03:05 EST 2025
Thu Sep 04 16:32:46 EDT 2025
Tue Oct 07 07:09:41 EDT 2025
Tue Nov 18 22:13:00 EST 2025
Sat Nov 29 07:14:17 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 17
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c386t-423c345af80779be9051984bfbebda4ef80bf7111a3ec0fd993407a6ac0a1d0e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Both Authors Contributed Equally to This Work.
ORCID 0000-0003-0278-5481
0000-0003-0560-5538
OpenAccessLink https://www.proquest.com/docview/2571317063?pq-origsite=%requestingapplication%
PMID 34501284
PQID 2571317063
PQPubID 5046890
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8432038
proquest_miscellaneous_2571921257
proquest_journals_2571317063
crossref_primary_10_3390_jcm10173837
crossref_citationtrail_10_3390_jcm10173837
PublicationCentury 2000
PublicationDate 20210826
PublicationDateYYYYMMDD 2021-08-26
PublicationDate_xml – month: 8
  year: 2021
  text: 20210826
  day: 26
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Journal of clinical medicine
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Gates (ref_24) 2014; 25
Spahr (ref_13) 2017; 4
Martin (ref_20) 2021; 102
Toskich (ref_7) 2019; 22
Jones (ref_14) 2012; 39
Grosser (ref_8) 2016; 57
Coudyzer (ref_11) 2019; 9
Meyer (ref_15) 2008; 190
Kafrouni (ref_18) 2019; 9
Bapst (ref_21) 2016; 39
Reiner (ref_12) 2012; 19
Ricke (ref_5) 2019; 71
Pasik (ref_10) 2020; 43
Gabr (ref_25) 2016; 43
Vilgrain (ref_4) 2017; 18
Jiang (ref_23) 2011; 26
Ilhan (ref_17) 2015; 56
Hinrichs (ref_19) 2016; 26
Garin (ref_6) 2013; 40
Jakobs (ref_1) 2007; 17
Forner (ref_2) 2010; 30
Henry (ref_22) 2019; 5
Ertreo (ref_9) 2018; 41
Chow (ref_3) 2018; 36
Lencioni (ref_16) 2010; 30
References_xml – volume: 5
  start-page: 055011
  year: 2019
  ident: ref_22
  article-title: Quantification of the inherent radiopacity of glass microspheres for precision dosimetry in yttrium-90 radioembolization
  publication-title: Biomed. Phys. Eng. Express.
  doi: 10.1088/2057-1976/ab36c2
– volume: 18
  start-page: 1624
  year: 2017
  ident: ref_4
  article-title: Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): An open-label randomised controlled phase 3 trial
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30683-6
– volume: 26
  start-page: 3447
  year: 2016
  ident: ref_19
  article-title: Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE
  publication-title: Eur. Radiol.
  doi: 10.1007/s00330-015-4203-4
– volume: 43
  start-page: 295
  year: 2020
  ident: ref_10
  article-title: Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT
  publication-title: Cardiovasc. Intervent. Radiol.
  doi: 10.1007/s00270-019-02198-6
– volume: 4
  start-page: 25
  year: 2017
  ident: ref_13
  article-title: Predictive SIRT dosimetry based on a territorial model
  publication-title: EJNMMI Phys.
  doi: 10.1186/s40658-017-0192-5
– volume: 30
  start-page: 61
  year: 2010
  ident: ref_2
  article-title: Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
  publication-title: Semin. Liver Dis.
  doi: 10.1055/s-0030-1247133
– volume: 17
  start-page: 1320
  year: 2007
  ident: ref_1
  article-title: Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using 90Yttrium resin-microspheres
  publication-title: Eur. Radiol.
  doi: 10.1007/s00330-006-0508-7
– volume: 190
  start-page: W263
  year: 2008
  ident: ref_15
  article-title: Visualization of Hypervascular Liver Lesions During TACE: Comparison of Angiographic C-Arm CT and MDCT
  publication-title: Am. J. Roentgenol.
  doi: 10.2214/AJR.07.2695
– volume: 19
  start-page: 613
  year: 2012
  ident: ref_12
  article-title: Liver Perfusion Imaging in Patients with Primary and Metastatic Liver Malignancy
  publication-title: Acad. Radiol.
  doi: 10.1016/j.acra.2011.12.015
– volume: 30
  start-page: 52
  year: 2010
  ident: ref_16
  article-title: Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
  publication-title: Semin. Liver Dis.
  doi: 10.1055/s-0030-1247132
– volume: 22
  start-page: 100
  year: 2019
  ident: ref_7
  article-title: Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist
  publication-title: Tec. Vas. Interv. Radiol.
  doi: 10.1053/j.tvir.2019.02.011
– volume: 39
  start-page: 4149
  year: 2012
  ident: ref_14
  article-title: Evaluation of the potential utility of flat panel CT for quantifying relative contrast enhancement: Potential utility of FPCT for quantifying relative enhancement
  publication-title: Med Phys.
  doi: 10.1118/1.4725711
– volume: 41
  start-page: 1857
  year: 2018
  ident: ref_9
  article-title: Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization
  publication-title: Cardiovasc. Intervent. Radiol.
  doi: 10.1007/s00270-018-2030-0
– volume: 9
  start-page: 62
  year: 2019
  ident: ref_18
  article-title: Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy
  publication-title: EJNMMI Res.
  doi: 10.1186/s13550-019-0533-6
– volume: 102
  start-page: 45
  year: 2021
  ident: ref_20
  article-title: Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres
  publication-title: Diagn. Interv. Imaging
  doi: 10.1016/j.diii.2020.09.003
– volume: 71
  start-page: 1164
  year: 2019
  ident: ref_5
  article-title: Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2019.08.006
– volume: 9
  start-page: 19
  year: 2019
  ident: ref_11
  article-title: Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization
  publication-title: EJNMMI Res.
  doi: 10.1186/s13550-019-0485-x
– volume: 39
  start-page: 8
  year: 2016
  ident: ref_21
  article-title: Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver
  publication-title: Cardiovasc. Intervent. Radiol.
  doi: 10.1007/s00270-015-1180-6
– volume: 25
  start-page: 266
  year: 2014
  ident: ref_24
  article-title: Outpatient Single-Session Yttrium-90 Glass Microsphere Radioembolization
  publication-title: J. Vas. Interv. Radiol.
  doi: 10.1016/j.jvir.2013.11.005
– volume: 56
  start-page: 1654
  year: 2015
  ident: ref_17
  article-title: Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.162685
– volume: 26
  start-page: 511
  year: 2011
  ident: ref_23
  article-title: Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy
  publication-title: Cancer Biother. Radiopharm.
– volume: 36
  start-page: 1913
  year: 2018
  ident: ref_3
  article-title: SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.0892
– volume: 57
  start-page: 925
  year: 2016
  ident: ref_8
  article-title: Pharmacokinetics of 99mTc-MAA- and 99mTc-HSA-Microspheres Used in Preradioembolization Dosimetry: Influence on the Liver-Lung Shunt
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.169987
– volume: 43
  start-page: 2353
  year: 2016
  ident: ref_25
  article-title: Same-day 90Y radioembolization: Implementing a new treatment paradigm
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-016-3438-x
– volume: 40
  start-page: 1057
  year: 2013
  ident: ref_6
  article-title: Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: A new personalized promising concept
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-013-2395-x
SSID ssj0000884217
Score 2.1770775
Snippet (1) Background: To comparatively analyze the uptake of hepatocellular carcinoma (HCC) on pre-therapeutic imaging modalities, the arterial phase multi-detector...
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 3837
SubjectTerms Abdomen
Clinical medicine
Iodine
Liver cancer
Patients
Radiation therapy
Scanners
Sensors
Tomography
Tumors
Veins & arteries
Title Comparison of the Uptake of Hepatocellular Carcinoma on Pre-Therapeutic MDCT, CACT, and SPECT/CT, and the Correlation with Post-Therapeutic PET/CT in Patients Undergoing Selective Internal Radiation Therapy
URI https://www.proquest.com/docview/2571317063
https://www.proquest.com/docview/2571921257
https://pubmed.ncbi.nlm.nih.gov/PMC8432038
Volume 10
WOSCitedRecordID wos000694392600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: BENPR
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: 7X7
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: PIMPY
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZYh9Be-I1WGJOR9oSImsVu4jyhETKNh1bR1knlKbIdexS2pLQZEi_8ifxN3CVuukiIF14iOXHOke58Pp8v30fIEWfMCMUCzwZGe9xa68VahoiMCOr2ZayZbcgmoulUzOdx5hJua1dWufGJjaMuKo058hGY1jFDrBf2fvndQ9YoPF11FBo7ZBeRyviA7H5Ip9l5l2WBOcQh6G5_zGOwvx991Tdohbgx6y9F2_iyXx15Z7k5ffS_H_qYPHSBJj1pLeMJuWfKp-TBxB2lPyO_k46BkFaWQhxIL5e1_GawdQaLVF1hUh-rVGmChENldSMpdM5Wxptt_9qik4_J7B1NTvAqy4JeZGkyG21aKDdBBpC25o5i3pciQ3BPRpbiG3QB0luc1zVtCJmuKlhZ6UXD1QNumbr85TU9R0iFRmAr5udzcnmazpIzz5E7eJqJsPYgjNOMj6UVfhTFyiBOWCy4ssqoQnID95WNwBNLZrRvC4ijYO8pQ6l9eVz4hr0gg7IqzT6hJuCh8lUoheXc-CzWIlQSvBODAMSMgyF5u9Fzrh3yORJwXOewA0KjyO8YxZAcdZ2XLeDH37sdbLSfu1m_zreqH5I33WOYr6gvWZrqtu0TQ7wwBhFRz9C64RDxu_-kXHxpkL8FZ4HPxMt_D_6K7AVYeeODDwwPyKBe3ZrX5L7-US_Wq0OyE82j5ioO3XSB1uRXCq3s0yT7_AcNXSTj
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELbKFgEX3oiFAkYqF0S0buzN44BQlW61q3ZXEU2lckodx4aFNll2U1D_FD-F38RMXttIiFsPXCIlccZS_GVm7Iy_j5Btwbn2Em5bxtbKEsYYy1fSQWZEGG4mfcVNKTbhzmbeyYkfbpBfzV4YLKtsfGLpqNNc4Rr5AKC1w5HrhX9YfLdQNQr_rjYSGhUsDvTlT5iyrd5P9mB839j2_igKxlatKmAp7jmFBfmD4mIojcdc1080ElT5nkhMopNUCg3XE-OCC5BcK2ZSCOAw6ZGOVEzupExzsHuDbAoAu9cjm-FkGn5qV3XgmxWQ5FcbATn32eCrOkfU40SwG_rW-Wy3GvNKeNu_97-9mPvkbp1I090K-Q_Ihs4eklvTulTgEfkdtAqLNDcU8lx6vCjkN41nYwjCRY4_LbAKlwYoqJTl55JC43CprWi9K41O94LoHQ128SizlB6FoyAaNGdoN0CFk6qmkOK6NkUF5I6NcIRP0DlYr3hsV7QUnPqcQ-ZAj0otIgg7tF6fPaMfkTKiNFiZuXxMjq_lbT4hvSzP9FNCtS2chCWO9IwQmnFfeU4iwftySLD00O6Ttw2uYlUzu6PAyFkMMzwEYXwFhH2y3TZeVIQmf2-21aAtrr3aKl5DrU9et7fBH-F4yUznF1UbH_KhIZhwO8Buu0NG8-6dbP6lZDb3BLcZ9579u_NX5PY4mh7Gh5PZwXNyx8YqIwb-3tkivWJ5oV-Qm-pHMV8tX9afJyWn1w38Py8rfow
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGhqa9cEeUXTDSeEFE9WI3lweEprTVqtEqYp00noLj2KywJV2bgfbX-BH8Js7JrYuEeNsDL5ESOyeS_Z2LnePzEbIvONdezG3L2FpZwhhj-Uo6WBkRpptJX3FTkE24k4l3duaHa-RXfRYG0yprm1gY6iRTuEfeBWgdcKz1wrumSosI-8MP8ysLGaTwT2tNp1FC5Fjf_ITl2_L9qA9z_ca2h4NpcGRVDAOW4p6TWxBLKC560njMdf1YY7Eq3xOxiXWcSKHheWxcMAeSa8VMAs4cFkDSkYrJg4RpDnLvkQ0IyQXo2EY4Goefmx0e0F8BAX95KJBzn3W_qUvUAFwUtt3gKrZtZ2becnXDh__zID0iD6oAmx6WGvGYrOn0CdkcVykET8nvoGFepJmhEP_S03kuv2u8OwLnnGf4MwOzc2mAREtpdikpdA4X2pquTqvRcT-YvqPBIV5lmtCTcBBMu_Udyg2Q-aTMNaS4302RGbklIxzgG3QG0sv6tktaEFF9zSCioCcFRxG4I1rt217QT1hKohBYirl5Rk7vZDSfk_U0S_ULQrUtnJjFjvSMEJpxX3lOLMEqcwi8dM_ukLc1xiJVVXxH4pGLCFZ-CMjoFiA7ZL_pPC8Lnfy9206NvKiydstoBbsOed00g53C-ZKpzq7LPj7EST0Q4bZA3nwOK523W9LZeVHx3BPcZtx7-e-PvyKbgPbo42hyvE22bEw-YuAGnB2yni-u9S65r37ks-Vir9JUSr7cNe7_ACUth0w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+Uptake+of+Hepatocellular+Carcinoma+on+Pre-Therapeutic+MDCT%2C+CACT%2C+and+SPECT%2FCT%2C+and+the+Correlation+with+Post-Therapeutic+PET%2FCT+in+Patients+Undergoing+Selective+Internal+Radiation+Therapy&rft.jtitle=Journal+of+clinical+medicine&rft.au=Meine%2C+Timo+C.&rft.au=Brunkhorst%2C+Thomas&rft.au=Werncke%2C+Thomas&rft.au=Sch%C3%BCtze%2C+Christian&rft.date=2021-08-26&rft.issn=2077-0383&rft.eissn=2077-0383&rft.volume=10&rft.issue=17&rft.spage=3837&rft_id=info:doi/10.3390%2Fjcm10173837&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_jcm10173837
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon